ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Follicular Lymphoma Drugs Market Research Report 2024
Published Date: March 2024
|
Report Code: QYRE-Auto-7Z9384
Home | Market Reports | Health| Health Conditions| Cancer
Global Follicular Lymphoma Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Follicular Lymphoma Drugs Market Research Report 2024

Code: QYRE-Auto-7Z9384
Report
March 2024
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Gilead Sciences
TG Therapeutics
Secura Bio
EpiZyme Inc
Eisai Co Ltd
Acrotech Biopharma
TEVA
Eagle Pharmaceuticals
Mundipharma
Bayer

Follicular Lymphoma Drugs Market Size

The global Follicular Lymphoma Drugs market was valued at US$ 1711.1 million in 2023 and is anticipated to reach US$ 2836.9 million by 2030, witnessing a CAGR of 7.4% during the forecast period 2024-2030.

Follicular Lymphoma Drugs Market

Follicular Lymphoma Drugs Market

Follicular lymphoma is a cancer that affects white blood cells called lymphocytes. There are two types of lymphomas: Hodgkin's and non-Hodgkin's, based on the kind of white blood cell they affect. Follicular lymphoma is a non-Hodgkin's lymphoma.Drugs for Follicular lymphoma are Anti-CD20 mAbs, Chemotherapy Agents, Kinase Inhibitor, etc.
Global core follicular lymphoma drugs players include Roche, Teva and Bayer etc. The Top3 companies hold a share about 57%. North America is the largest market, with a share about 58%, followed by Europe and Asia Pacific with the share about 21% and 20%.
This report aims to provide a comprehensive presentation of the global market for Follicular Lymphoma Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Follicular Lymphoma Drugs.

Report Scope

The Follicular Lymphoma Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Follicular Lymphoma Drugs market comprehensively. Regional market sizes, concerning products by Type, by Administration Route, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Follicular Lymphoma Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Administration Route, and by regions.
Market Segmentation

Scope of Follicular Lymphoma Drugs Market Report

Report Metric Details
Report Name Follicular Lymphoma Drugs Market
Accounted market size in 2023 US$ 1711.1 million
Forecasted market size in 2030 US$ 2836.9 million
CAGR 7.4%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Anti-CD20 mAbs
  • Chemotherapy Agents
  • Kinase Inhibitor
  • Others
Segment by Administration Route
  • Injection
  • Oral
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Gilead Sciences, TG Therapeutics, Bayer, Secura Bio, Epizyme, Eisai, Acrotech Biopharma, Teva, Eagle Pharmaceuticals, MundiPharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Administration Route, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Follicular Lymphoma Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Administration Route, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Follicular Lymphoma Drugs Market growing?

Ans: The Follicular Lymphoma Drugs Market witnessing a CAGR of 7.4% during the forecast period 2024-2030.

What is the Follicular Lymphoma Drugs Market size in 2030?

Ans: The Follicular Lymphoma Drugs Market size in 2030 will be US$ 2836.9 million.

What is the Follicular Lymphoma Drugs Market share by region?

Ans: North America is the largest market, with a share about 58%, followed by Europe and Asia Pacific with the share about 21% and 20%.

Who are the main players in the Follicular Lymphoma Drugs Market report?

Ans: The main players in the Follicular Lymphoma Drugs Market are Roche, Gilead Sciences, TG Therapeutics, Bayer, Secura Bio, Epizyme, Eisai, Acrotech Biopharma, Teva, Eagle Pharmaceuticals, MundiPharma

What are the Type segmentation covered in the Follicular Lymphoma Drugs Market report?

Ans: The Types covered in the Follicular Lymphoma Drugs Market report are Anti-CD20 mAbs, Chemotherapy Agents, Kinase Inhibitor, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Follicular Lymphoma Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Anti-CD20 mAbs
1.2.3 Chemotherapy Agents
1.2.4 Kinase Inhibitor
1.2.5 Others
1.3 Market by Administration Route
1.3.1 Global Follicular Lymphoma Drugs Market Growth by Administration Route: 2019 VS 2023 VS 2030
1.3.2 Injection
1.3.3 Oral
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Follicular Lymphoma Drugs Market Perspective (2019-2030)
2.2 Follicular Lymphoma Drugs Growth Trends by Region
2.2.1 Global Follicular Lymphoma Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Follicular Lymphoma Drugs Historic Market Size by Region (2019-2024)
2.2.3 Follicular Lymphoma Drugs Forecasted Market Size by Region (2025-2030)
2.3 Follicular Lymphoma Drugs Market Dynamics
2.3.1 Follicular Lymphoma Drugs Industry Trends
2.3.2 Follicular Lymphoma Drugs Market Drivers
2.3.3 Follicular Lymphoma Drugs Market Challenges
2.3.4 Follicular Lymphoma Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Follicular Lymphoma Drugs Players by Revenue
3.1.1 Global Top Follicular Lymphoma Drugs Players by Revenue (2019-2024)
3.1.2 Global Follicular Lymphoma Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Follicular Lymphoma Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Follicular Lymphoma Drugs Revenue
3.4 Global Follicular Lymphoma Drugs Market Concentration Ratio
3.4.1 Global Follicular Lymphoma Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Follicular Lymphoma Drugs Revenue in 2023
3.5 Follicular Lymphoma Drugs Key Players Head office and Area Served
3.6 Key Players Follicular Lymphoma Drugs Product Solution and Service
3.7 Date of Enter into Follicular Lymphoma Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Follicular Lymphoma Drugs Breakdown Data by Type
4.1 Global Follicular Lymphoma Drugs Historic Market Size by Type (2019-2024)
4.2 Global Follicular Lymphoma Drugs Forecasted Market Size by Type (2025-2030)
5 Follicular Lymphoma Drugs Breakdown Data by Administration Route
5.1 Global Follicular Lymphoma Drugs Historic Market Size by Administration Route (2019-2024)
5.2 Global Follicular Lymphoma Drugs Forecasted Market Size by Administration Route (2025-2030)
6 North America
6.1 North America Follicular Lymphoma Drugs Market Size (2019-2030)
6.2 North America Follicular Lymphoma Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Follicular Lymphoma Drugs Market Size by Country (2019-2024)
6.4 North America Follicular Lymphoma Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Follicular Lymphoma Drugs Market Size (2019-2030)
7.2 Europe Follicular Lymphoma Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Follicular Lymphoma Drugs Market Size by Country (2019-2024)
7.4 Europe Follicular Lymphoma Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Follicular Lymphoma Drugs Market Size (2019-2030)
8.2 Asia-Pacific Follicular Lymphoma Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Follicular Lymphoma Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Follicular Lymphoma Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Follicular Lymphoma Drugs Market Size (2019-2030)
9.2 Latin America Follicular Lymphoma Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Follicular Lymphoma Drugs Market Size by Country (2019-2024)
9.4 Latin America Follicular Lymphoma Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Follicular Lymphoma Drugs Market Size (2019-2030)
10.2 Middle East & Africa Follicular Lymphoma Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Follicular Lymphoma Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Follicular Lymphoma Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Follicular Lymphoma Drugs Introduction
11.1.4 Roche Revenue in Follicular Lymphoma Drugs Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Detail
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Follicular Lymphoma Drugs Introduction
11.2.4 Gilead Sciences Revenue in Follicular Lymphoma Drugs Business (2019-2024)
11.2.5 Gilead Sciences Recent Development
11.3 TG Therapeutics
11.3.1 TG Therapeutics Company Detail
11.3.2 TG Therapeutics Business Overview
11.3.3 TG Therapeutics Follicular Lymphoma Drugs Introduction
11.3.4 TG Therapeutics Revenue in Follicular Lymphoma Drugs Business (2019-2024)
11.3.5 TG Therapeutics Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer Follicular Lymphoma Drugs Introduction
11.4.4 Bayer Revenue in Follicular Lymphoma Drugs Business (2019-2024)
11.4.5 Bayer Recent Development
11.5 Secura Bio
11.5.1 Secura Bio Company Detail
11.5.2 Secura Bio Business Overview
11.5.3 Secura Bio Follicular Lymphoma Drugs Introduction
11.5.4 Secura Bio Revenue in Follicular Lymphoma Drugs Business (2019-2024)
11.5.5 Secura Bio Recent Development
11.6 Epizyme
11.6.1 Epizyme Company Detail
11.6.2 Epizyme Business Overview
11.6.3 Epizyme Follicular Lymphoma Drugs Introduction
11.6.4 Epizyme Revenue in Follicular Lymphoma Drugs Business (2019-2024)
11.6.5 Epizyme Recent Development
11.7 Eisai
11.7.1 Eisai Company Detail
11.7.2 Eisai Business Overview
11.7.3 Eisai Follicular Lymphoma Drugs Introduction
11.7.4 Eisai Revenue in Follicular Lymphoma Drugs Business (2019-2024)
11.7.5 Eisai Recent Development
11.8 Acrotech Biopharma
11.8.1 Acrotech Biopharma Company Detail
11.8.2 Acrotech Biopharma Business Overview
11.8.3 Acrotech Biopharma Follicular Lymphoma Drugs Introduction
11.8.4 Acrotech Biopharma Revenue in Follicular Lymphoma Drugs Business (2019-2024)
11.8.5 Acrotech Biopharma Recent Development
11.9 Teva
11.9.1 Teva Company Detail
11.9.2 Teva Business Overview
11.9.3 Teva Follicular Lymphoma Drugs Introduction
11.9.4 Teva Revenue in Follicular Lymphoma Drugs Business (2019-2024)
11.9.5 Teva Recent Development
11.10 Eagle Pharmaceuticals
11.10.1 Eagle Pharmaceuticals Company Detail
11.10.2 Eagle Pharmaceuticals Business Overview
11.10.3 Eagle Pharmaceuticals Follicular Lymphoma Drugs Introduction
11.10.4 Eagle Pharmaceuticals Revenue in Follicular Lymphoma Drugs Business (2019-2024)
11.10.5 Eagle Pharmaceuticals Recent Development
11.11 MundiPharma
11.11.1 MundiPharma Company Detail
11.11.2 MundiPharma Business Overview
11.11.3 MundiPharma Follicular Lymphoma Drugs Introduction
11.11.4 MundiPharma Revenue in Follicular Lymphoma Drugs Business (2019-2024)
11.11.5 MundiPharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Roche
Gilead Sciences
TG Therapeutics
Secura Bio
EpiZyme Inc
Eisai Co Ltd
Acrotech Biopharma
TEVA
Eagle Pharmaceuticals
Mundipharma
Bayer
List of Tables
    Table 1. Global Follicular Lymphoma Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Anti-CD20 mAbs
    Table 3. Key Players of Chemotherapy Agents
    Table 4. Key Players of Kinase Inhibitor
    Table 5. Key Players of Others
    Table 6. Global Follicular Lymphoma Drugs Market Size Growth by Administration Route (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Follicular Lymphoma Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Follicular Lymphoma Drugs Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Follicular Lymphoma Drugs Market Share by Region (2019-2024)
    Table 10. Global Follicular Lymphoma Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Follicular Lymphoma Drugs Market Share by Region (2025-2030)
    Table 12. Follicular Lymphoma Drugs Market Trends
    Table 13. Follicular Lymphoma Drugs Market Drivers
    Table 14. Follicular Lymphoma Drugs Market Challenges
    Table 15. Follicular Lymphoma Drugs Market Restraints
    Table 16. Global Follicular Lymphoma Drugs Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Follicular Lymphoma Drugs Market Share by Players (2019-2024)
    Table 18. Global Top Follicular Lymphoma Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Follicular Lymphoma Drugs as of 2023)
    Table 19. Ranking of Global Top Follicular Lymphoma Drugs Companies by Revenue (US$ Million) in 2023
    Table 20. Global 5 Largest Players Market Share by Follicular Lymphoma Drugs Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Follicular Lymphoma Drugs Product Solution and Service
    Table 23. Date of Enter into Follicular Lymphoma Drugs Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Follicular Lymphoma Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Follicular Lymphoma Drugs Revenue Market Share by Type (2019-2024)
    Table 27. Global Follicular Lymphoma Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Follicular Lymphoma Drugs Revenue Market Share by Type (2025-2030)
    Table 29. Global Follicular Lymphoma Drugs Market Size by Administration Route (2019-2024) & (US$ Million)
    Table 30. Global Follicular Lymphoma Drugs Revenue Market Share by Administration Route (2019-2024)
    Table 31. Global Follicular Lymphoma Drugs Forecasted Market Size by Administration Route (2025-2030) & (US$ Million)
    Table 32. Global Follicular Lymphoma Drugs Revenue Market Share by Administration Route (2025-2030)
    Table 33. North America Follicular Lymphoma Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 34. North America Follicular Lymphoma Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 35. North America Follicular Lymphoma Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 36. Europe Follicular Lymphoma Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. Europe Follicular Lymphoma Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 38. Europe Follicular Lymphoma Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Asia-Pacific Follicular Lymphoma Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 40. Asia-Pacific Follicular Lymphoma Drugs Market Size by Region (2019-2024) & (US$ Million)
    Table 41. Asia-Pacific Follicular Lymphoma Drugs Market Size by Region (2025-2030) & (US$ Million)
    Table 42. Latin America Follicular Lymphoma Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Latin America Follicular Lymphoma Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Follicular Lymphoma Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Follicular Lymphoma Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Middle East & Africa Follicular Lymphoma Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Middle East & Africa Follicular Lymphoma Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 48. Roche Company Detail
    Table 49. Roche Business Overview
    Table 50. Roche Follicular Lymphoma Drugs Product
    Table 51. Roche Revenue in Follicular Lymphoma Drugs Business (2019-2024) & (US$ Million)
    Table 52. Roche Recent Development
    Table 53. Gilead Sciences Company Detail
    Table 54. Gilead Sciences Business Overview
    Table 55. Gilead Sciences Follicular Lymphoma Drugs Product
    Table 56. Gilead Sciences Revenue in Follicular Lymphoma Drugs Business (2019-2024) & (US$ Million)
    Table 57. Gilead Sciences Recent Development
    Table 58. TG Therapeutics Company Detail
    Table 59. TG Therapeutics Business Overview
    Table 60. TG Therapeutics Follicular Lymphoma Drugs Product
    Table 61. TG Therapeutics Revenue in Follicular Lymphoma Drugs Business (2019-2024) & (US$ Million)
    Table 62. TG Therapeutics Recent Development
    Table 63. Bayer Company Detail
    Table 64. Bayer Business Overview
    Table 65. Bayer Follicular Lymphoma Drugs Product
    Table 66. Bayer Revenue in Follicular Lymphoma Drugs Business (2019-2024) & (US$ Million)
    Table 67. Bayer Recent Development
    Table 68. Secura Bio Company Detail
    Table 69. Secura Bio Business Overview
    Table 70. Secura Bio Follicular Lymphoma Drugs Product
    Table 71. Secura Bio Revenue in Follicular Lymphoma Drugs Business (2019-2024) & (US$ Million)
    Table 72. Secura Bio Recent Development
    Table 73. Epizyme Company Detail
    Table 74. Epizyme Business Overview
    Table 75. Epizyme Follicular Lymphoma Drugs Product
    Table 76. Epizyme Revenue in Follicular Lymphoma Drugs Business (2019-2024) & (US$ Million)
    Table 77. Epizyme Recent Development
    Table 78. Eisai Company Detail
    Table 79. Eisai Business Overview
    Table 80. Eisai Follicular Lymphoma Drugs Product
    Table 81. Eisai Revenue in Follicular Lymphoma Drugs Business (2019-2024) & (US$ Million)
    Table 82. Eisai Recent Development
    Table 83. Acrotech Biopharma Company Detail
    Table 84. Acrotech Biopharma Business Overview
    Table 85. Acrotech Biopharma Follicular Lymphoma Drugs Product
    Table 86. Acrotech Biopharma Revenue in Follicular Lymphoma Drugs Business (2019-2024) & (US$ Million)
    Table 87. Acrotech Biopharma Recent Development
    Table 88. Teva Company Detail
    Table 89. Teva Business Overview
    Table 90. Teva Follicular Lymphoma Drugs Product
    Table 91. Teva Revenue in Follicular Lymphoma Drugs Business (2019-2024) & (US$ Million)
    Table 92. Teva Recent Development
    Table 93. Eagle Pharmaceuticals Company Detail
    Table 94. Eagle Pharmaceuticals Business Overview
    Table 95. Eagle Pharmaceuticals Follicular Lymphoma Drugs Product
    Table 96. Eagle Pharmaceuticals Revenue in Follicular Lymphoma Drugs Business (2019-2024) & (US$ Million)
    Table 97. Eagle Pharmaceuticals Recent Development
    Table 98. MundiPharma Company Detail
    Table 99. MundiPharma Business Overview
    Table 100. MundiPharma Follicular Lymphoma Drugs Product
    Table 101. MundiPharma Revenue in Follicular Lymphoma Drugs Business (2019-2024) & (US$ Million)
    Table 102. MundiPharma Recent Development
    Table 103. Research Programs/Design for This Report
    Table 104. Key Data Information from Secondary Sources
    Table 105. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Follicular Lymphoma Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Follicular Lymphoma Drugs Market Share by Type: 2023 VS 2030
    Figure 3. Anti-CD20 mAbs Features
    Figure 4. Chemotherapy Agents Features
    Figure 5. Kinase Inhibitor Features
    Figure 6. Others Features
    Figure 7. Global Follicular Lymphoma Drugs Market Size Comparison by Administration Route (2024-2030) & (US$ Million)
    Figure 8. Global Follicular Lymphoma Drugs Market Share by Administration Route: 2023 VS 2030
    Figure 9. Injection Case Studies
    Figure 10. Oral Case Studies
    Figure 11. Follicular Lymphoma Drugs Report Years Considered
    Figure 12. Global Follicular Lymphoma Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Follicular Lymphoma Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Follicular Lymphoma Drugs Market Share by Region: 2023 VS 2030
    Figure 15. Global Follicular Lymphoma Drugs Market Share by Players in 2023
    Figure 16. Global Top Follicular Lymphoma Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Follicular Lymphoma Drugs as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Follicular Lymphoma Drugs Revenue in 2023
    Figure 18. North America Follicular Lymphoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Follicular Lymphoma Drugs Market Share by Country (2019-2030)
    Figure 20. United States Follicular Lymphoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Canada Follicular Lymphoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Follicular Lymphoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Follicular Lymphoma Drugs Market Share by Country (2019-2030)
    Figure 24. Germany Follicular Lymphoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. France Follicular Lymphoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. U.K. Follicular Lymphoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Italy Follicular Lymphoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Russia Follicular Lymphoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Nordic Countries Follicular Lymphoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Asia-Pacific Follicular Lymphoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Asia-Pacific Follicular Lymphoma Drugs Market Share by Region (2019-2030)
    Figure 32. China Follicular Lymphoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Japan Follicular Lymphoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. South Korea Follicular Lymphoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Southeast Asia Follicular Lymphoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. India Follicular Lymphoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Australia Follicular Lymphoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Latin America Follicular Lymphoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Latin America Follicular Lymphoma Drugs Market Share by Country (2019-2030)
    Figure 40. Mexico Follicular Lymphoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Brazil Follicular Lymphoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Middle East & Africa Follicular Lymphoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Middle East & Africa Follicular Lymphoma Drugs Market Share by Country (2019-2030)
    Figure 44. Turkey Follicular Lymphoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Saudi Arabia Follicular Lymphoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Roche Revenue Growth Rate in Follicular Lymphoma Drugs Business (2019-2024)
    Figure 47. Gilead Sciences Revenue Growth Rate in Follicular Lymphoma Drugs Business (2019-2024)
    Figure 48. TG Therapeutics Revenue Growth Rate in Follicular Lymphoma Drugs Business (2019-2024)
    Figure 49. Bayer Revenue Growth Rate in Follicular Lymphoma Drugs Business (2019-2024)
    Figure 50. Secura Bio Revenue Growth Rate in Follicular Lymphoma Drugs Business (2019-2024)
    Figure 51. Epizyme Revenue Growth Rate in Follicular Lymphoma Drugs Business (2019-2024)
    Figure 52. Eisai Revenue Growth Rate in Follicular Lymphoma Drugs Business (2019-2024)
    Figure 53. Acrotech Biopharma Revenue Growth Rate in Follicular Lymphoma Drugs Business (2019-2024)
    Figure 54. Teva Revenue Growth Rate in Follicular Lymphoma Drugs Business (2019-2024)
    Figure 55. Eagle Pharmaceuticals Revenue Growth Rate in Follicular Lymphoma Drugs Business (2019-2024)
    Figure 56. MundiPharma Revenue Growth Rate in Follicular Lymphoma Drugs Business (2019-2024)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Colon Cancer Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-31C5944
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global CAR T-Cell Immunotherapy Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-10J13802
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Color Detection Sensors Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-6G9623
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Appendix Cancer Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-2H1312
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions